Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 7 September 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 209 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 5 results:
Author Title [ Type(Asc)] Year
Filters: Author is Griffiths, R. I.  [Clear All Filters]
Journal Article
R. I. Griffiths, McFadden, E. C., Stevens, R. J., Valderas, J. M., Lavery, B. A., Khan, N. F., Keating, N. L., and Bankhead, C. R., “Quality of diabetes care in breast, colorectal, and prostate cancer”, J Cancer Surviv, vol. 12, pp. 803-812, 2018.
R. I. Griffiths, Valderas, J. M., McFadden, E. C., Bankhead, C. R., Lavery, B. A., Khan, N. F., Stevens, R. J., and Keating, N. L., “Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer”, J Cancer Surviv, vol. 11, pp. 604-613, 2017.
M. D. Danese, Gleeson, M., Griffiths, R. I., Catterick, D., and Kutikova, L., “Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom”, J Med Econ, vol. 20, pp. 931-937, 2017.
M. D. Danese, Gleeson, M., Kutikova, L., Griffiths, R. I., Khunti, K., Seshasai, S. R. K., and Ray, K. K., “Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study”, BMJ Open, vol. 7, p. e013851, 2017.
M. D. Danese, Gleeson, M., Kutikova, L., Griffiths, R. I., Azough, A., Khunti, K., Seshasai, S. R., and Ray, K. K., “Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK”, BMJ Open, vol. 6, p. e011805, 2016.
[Page last reviewed 7 September 2020]